New EEG measures at the beginning of MDD rTMS treatment predict its efficiency: preliminary results Conference Paper uri icon


  • Background: In recent years, many electroencephalography (EEG)-based predictors for major depressive disorder (MDD) treatment outcomes have been reported. These studies attempted to classify subjects as future responders/non-responders by measures taken before treatment. In this study, we examined a novel EEG measure, ongoing Brain Network Activation (oBNA), acquired during repetitive transcranial magnetic stimulation (rTMS) treatment, as a potential predictor of treatment efficiency.

publication date

  • January 1, 2017